PDE6B and tuberculosis: Among the patients without active TB, 15.6% (5/32) of the subjects classified as “mitogen-responsive” responded to the assays based on IFN-γ in response to RD1 selected peptides compared to 50.0% (3/6) of the “mitogen-unresponsive” (p = 0.09).